Literature DB >> 15665542

Rectal cancer with paraneoplastic nephropathy: association of vascular endothelial growth factor.

Ken Taniguchi1, Hikaru Fujioka, Yasuhiro Torashima, Junzo Yamaguchi, Kunihide Izawa, Takashi Kanematsu.   

Abstract

A patient with advanced rectal cancer was complicated by progressing proteinuria and hypoproteinemia. Low anterior resection was a procedure of choice. A surgical specimen obtained by intraoperative renal biopsy showed the findings of minimal change nephrotic syndrome. After surgery, nephropathy remitted promptly and completely. Her pre/postoperative serum level of vascular endothelial growth factor was 1,880/52.3 pg/ml, suggesting its elevation was associated with the nephropathy. Immunohistochemistry revealed strongly expressed tumor vascular endothelial cell growth factor. Minimal change nephrotic syndrome is a rare type of paraneoplastic nephropathy, and successful remission may require therapeutic resection of the underlying tumor, or administration of a vascular endothelial growth factor antagonist if the tumor is unresectable. Copyright 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665542     DOI: 10.1159/000083474

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  3 in total

Review 1.  Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis.

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Nat Rev Nephrol       Date:  2010-12-14       Impact factor: 28.314

2.  Concurrent minimal change disease and retroperitoneal liposarcoma successfully treated by tumor resection and steroid therapy.

Authors:  Yuki Yasui; Ryoko Shibata; Natsumi Morita; Naoko Himuro; Aki Hamauchi; Maho Watanabe; Kenji Ito; Tetsuhiko Yasuno; Yasuhiro Abe; Katsuhisa Miyake; Fumihiro Yoshimura; Makoto Hamsaki; Satoshi Hisano; Kosuke Masutani; Hitoshi Nakashima
Journal:  CEN Case Rep       Date:  2020-09-09

3.  Minimal change disease associated with gastrointestinal stromal tumor accompanied by significantly elevated serum IgE level: a case report.

Authors:  Chun-Yang Yu; Jie Liu; Chang-Hai Qi; Zhen-Yu Wu; Yue-Fei Xiao; Xue-Guang Zhang
Journal:  BMC Nephrol       Date:  2022-04-11       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.